Pharmacokinetics and Safety of Levofloxacin for Treatment of RifampicinResistant Tuberculosis During Pregnancy and the Postpartum Period Results from IMPAACT P1026s

Simple item page
dc.article.end-page630en
dc.article.start-page619en
dc.citation.doi10.1007/S40262-025-01498-0en
dc.contributor.authorJennifer A Hughesen
dc.contributor.authorMauricio Pinillaen
dc.contributor.authorKristina M Brooksen
dc.contributor.authorAhizechukwu C Ekeen
dc.contributor.authorLee Fairlieen
dc.contributor.authorE et alen
dc.date.accessioned2026-03-26T14:20:57Z
dc.departmentWITS REPRODUCTIVE HEALTH AND HIV INSTITUTEen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0312-5963en
dc.identifier.urihttps://hdl.handle.net/10539/48740
dc.journal.titlePharmacokinetics and Safety of Levofloxacin for Treatment of RifampicinResistant Tuberculosis During Pregnancy and the Postpartum Period Results from IMPAACT P1026sen
dc.journal.volume64en
dc.publisherADIS INT LTDen
dc.titlePharmacokinetics and Safety of Levofloxacin for Treatment of RifampicinResistant Tuberculosis During Pregnancy and the Postpartum Period Results from IMPAACT P1026sen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
718.72 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)